These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27336669)

  • 1. Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis.
    Omata Y; Nakamura S; Koyama T; Yasui T; Hirose J; Izawa N; Matsumoto T; Imai Y; Seo S; Kurokawa M; Tsutsumi S; Kadono Y; Morimoto C; Aburatani H; Miyamoto T; Tanaka S
    PLoS One; 2016; 11(6):e0157992. PubMed ID: 27336669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6.
    Yasui T; Kadono Y; Nakamura M; Oshima Y; Matsumoto T; Masuda H; Hirose J; Omata Y; Yasuda H; Imamura T; Nakamura K; Tanaka S
    J Bone Miner Res; 2011 Jul; 26(7):1447-56. PubMed ID: 21305609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomewide comprehensive analysis reveals critical cooperation between Smad and c-Fos in RANKL-induced osteoclastogenesis.
    Omata Y; Yasui T; Hirose J; Izawa N; Imai Y; Matsumoto T; Masuda H; Tokuyama N; Nakamura S; Tsutsumi S; Yasuda H; Okamoto K; Takayanagi H; Hikita A; Imamura T; Matsuo K; Saito T; Kadono Y; Aburatani H; Tanaka S
    J Bone Miner Res; 2015 May; 30(5):869-77. PubMed ID: 25431176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1.
    Yasui T; Hirose J; Tsutsumi S; Nakamura K; Aburatani H; Tanaka S
    J Bone Miner Res; 2011 Nov; 26(11):2665-71. PubMed ID: 21735477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global epigenomic analysis indicates protocadherin-7 activates osteoclastogenesis by promoting cell-cell fusion.
    Nakamura H; Nakashima T; Hayashi M; Izawa N; Yasui T; Aburatani H; Tanaka S; Takayanagi H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):305-11. PubMed ID: 25446128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1.
    Nakamura S; Koyama T; Izawa N; Nomura S; Fujita T; Omata Y; Minami T; Matsumoto M; Nakamura M; Fujita-Jimbo E; Momoi T; Miyamoto T; Aburatani H; Tanaka S
    PLoS One; 2017; 12(4):e0175632. PubMed ID: 28414795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
    Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
    Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway.
    Wakabayashi Y; Tamiya T; Takada I; Fukaya T; Sugiyama Y; Inoue N; Kimura A; Morita R; Kashiwagi I; Takimoto T; Nomura M; Yoshimura A
    J Biol Chem; 2011 Oct; 286(41):35456-35465. PubMed ID: 21862595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
    Brown KA; Pietenpol JA; Moses HL
    J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
    Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis.
    Huang W; Drissi MH; O'Keefe RJ; Schwarz EM
    Calcif Tissue Int; 2003 Dec; 73(6):584-93. PubMed ID: 14517717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation.
    Li TF; Darowish M; Zuscik MJ; Chen D; Schwarz EM; Rosier RN; Drissi H; O'Keefe RJ
    J Bone Miner Res; 2006 Jan; 21(1):4-16. PubMed ID: 16355269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts.
    Brazier H; Stephens S; Ory S; Fort P; Morrison N; Blangy A
    J Bone Miner Res; 2006 Sep; 21(9):1387-98. PubMed ID: 16939397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of osteoclast differentiation.
    Yasui T; Hirose J; Aburatani H; Tanaka S
    Ann N Y Acad Sci; 2011 Dec; 1240():7-13. PubMed ID: 22172033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.
    Koinuma D; Tsutsumi S; Kamimura N; Taniguchi H; Miyazawa K; Sunamura M; Imamura T; Miyazono K; Aburatani H
    Mol Cell Biol; 2009 Jan; 29(1):172-86. PubMed ID: 18955504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.